These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17362758)

  • 1. The effects of rapamycin in the progression of renal fibrosis.
    Damião MJ; Bertocchi AP; Monteiro RM; Gonçalves GM; Cenedeze MA; Feitoza CQ; Marques GD; Giannocco G; Mazzali M; Teixeira VP; Dos Reis MA; Pacheco-Silva A; Câmara NO
    Transplant Proc; 2007 Mar; 39(2):457-9. PubMed ID: 17362758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
    Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
    Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.
    Morrissey J; Hruska K; Guo G; Wang S; Chen Q; Klahr S
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S14-21. PubMed ID: 11792757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
    Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
    J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function.
    Klahr S
    J Nephrol; 2003; 16(2):179-85. PubMed ID: 12768064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury.
    Liu M; Agreda P; Crow M; Racusen L; Rabb H
    Transplant Proc; 2009 Dec; 41(10):4065-71. PubMed ID: 20005342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
    Negri AL
    J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.
    Zeisberg M; Bottiglio C; Kumar N; Maeshima Y; Strutz F; Müller GA; Kalluri R
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1060-7. PubMed ID: 12915382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.
    Sugimoto H; Grahovac G; Zeisberg M; Kalluri R
    Diabetes; 2007 Jul; 56(7):1825-33. PubMed ID: 17456853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury.
    Gonçalves GM; Cenedeze MA; Feitoza CQ; de Paula CB; Marques GD; Pinheiro HS; de Paula Antunes Teixeira V; Antônia dos Reis M; Pacheco-Silva A; Câmara NO
    Transplant Proc; 2007 Mar; 39(2):417-20. PubMed ID: 17362745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.
    Brook NR; Waller JR; Bicknell GR; Nicholson ML
    Transplant Proc; 2005 Mar; 37(2):837-8. PubMed ID: 15848549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.
    Fervenza FC; Fitzpatrick PM; Mertz J; Erickson SB; Liggett S; Popham S; Wochos DN; Synhavsky A; Hippler S; Larson TS; Bagniewski SM; Velosa JA;
    Nephrol Dial Transplant; 2004 May; 19(5):1288-92. PubMed ID: 15102967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine-A induced nephrotoxicity is associated with decreased renal bone morphogenetic protein-7 expression in rats.
    Tuğlular S; Gogas Yavuz D; Cakalağaoğlu F; Citak L; Arikan H; Koçak H; Ozener C; Akoğlu E
    Transplant Proc; 2004; 36(1):131-3. PubMed ID: 15013323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BMP-7 (Bone morphogenetic protein-7): a future treatment for chronic renal failure?].
    Niksic L; Martin PY
    Rev Med Suisse; 2005 Feb; 1(8):568-70, 572-3. PubMed ID: 15794307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rapamycin on renal ischemia-reperfusion injury in mice.
    Lui SL; Chan KW; Tsang R; Yung S; Lai KN; Chan TM
    Transpl Int; 2006 Oct; 19(10):834-9. PubMed ID: 16961776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin attenuates the severity of murine adriamycin nephropathy.
    Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
    Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition.
    Park SH; Choi MJ; Song IK; Choi SY; Nam JO; Kim CD; Lee BH; Park RW; Park KM; Kim YJ; Kim IS; Kwon TH; Kim YL
    J Am Soc Nephrol; 2007 May; 18(5):1497-507. PubMed ID: 17389738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
    Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
    Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.